Brief: Mersana Therapeutics Q3 EPS USD -1.51
14/11/2025 12:00
Nov 14 (Reuters) - Mersana Therapeutics Q3 collaboration revenue USD 11.009 million. Q3 net income USD -7.545 million
MRSN — Mersana Therapeutics News Story
0.000.00%
Last trade - 00:00- $145.16m
- $88.77m
- $40.50m